Who Qualifies for Weight Loss Medication? BMI and Health Criteria in Australia

A common question patients ask before booking a consultation is whether they would even be considered for prescription weight loss medication. The honest answer is that there is no single number that decides for everyone, but Australian clinical guidelines do reference clear starting points that practitioners work from. Understanding what those starting points are, and the wider clinical picture practitioners assess alongside them, helps patients form a realistic expectation before their consultation.

This article is general information only. It is not a self-qualification tool, and it does not describe any specific service. Whether prescription weight loss medication is appropriate for any individual depends on a clinical assessment by a registered practitioner who has reviewed the patient's full circumstances.

What Australian Clinical Guidelines Reference

Several Australian clinical resources guide practitioners on when to consider prescription weight loss medication. The most commonly cited include:

• The National Health and Medical Research Council's Clinical Practice Guidelines for the Management of Overweight and Obesity, originally published in 2013, with updated guidelines currently in public consultation through the Department of Health and Aged Care.

• The Royal Australian College of General Practitioners' position statement on obesity prevention and management, and its preventive activities resource for general practice.

• The Australian Obesity Management Algorithm, developed jointly by the Australian and New Zealand Obesity Society, the Australian Diabetes Society, the Australian and New Zealand Metabolic and Obesity Surgery Society, and the Royal Australian College of General Practitioners.

These resources are consistent on one point. Weight is not assessed in isolation. The clinician integrates the patient's body mass index with their broader health picture, their history, and their preferences before any decision is made.

The Starting Points Practitioners Reference

Although every consultation is individual, Australian clinical guidelines reference standard starting points when discussing whether prescription weight loss medication may be considered. In general terms, these are:

• a body mass index of 30 or above

• a body mass index of 27 or above when a weight-related health condition is also present

The weight-related health conditions most commonly cited include type 2 diabetes, prediabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, polycystic ovary syndrome, non-alcoholic fatty liver disease, and cardiovascular disease.

These figures are starting points for clinical conversation, not eligibility tests a patient can apply to themselves. Two patients at the same body mass index can reach quite different recommendations because the rest of their clinical picture is different. A practitioner is the right person to apply the framework to an individual situation.

Lower Thresholds for Some Populations

Australian clinical thinking recognises that body mass index thresholds work differently in different populations. The World Health Organization and Australian clinical sources both acknowledge that weight-related health risks present at lower body mass index ranges in some communities. Specifically:

• Lower thresholds are commonly referenced for patients of Asian, South Asian, and Aboriginal and Torres Strait Islander backgrounds.

• The Pharmaceutical Benefits Scheme reflects this in some of its current eligibility rules, where the threshold for certain prescription weight loss medications under PBS subsidy is lower for these patients than the standard general population threshold.

Practitioners are expected to apply these lower thresholds where they are clinically appropriate. Patients from these backgrounds should expect the conversation to take their broader cardiometabolic risk profile into account rather than relying solely on the standard general-population body mass index categories.

Why BMI Alone Is Not the Full Picture

Body mass index is a calculation based on height and weight. It is one input, and current Australian clinical thinking has moved increasingly toward looking at body mass index alongside other indicators rather than relying on it in isolation. Most practitioners will also consider:

• Waist circumference, which gives additional information about cardiometabolic risk independent of body mass index. Australian guidelines reference waist circumference cut-offs for both men and women, with lower cut-offs for some populations.

• Cardiometabolic markers, including fasting glucose, glycated haemoglobin (HbA1c), blood pressure, and a lipid profile.

• Coexisting conditions, including those listed earlier.

• Family history, particularly of cardiovascular disease, type 2 diabetes, and related conditions.

• Symptoms the patient is experiencing, including joint pain, breathlessness, fatigue, and sleep disturbance.

• Functional impact, including how weight is affecting daily life, mobility, and quality of life.

This broader view often matters more than the body mass index number alone. A patient with a body mass index just under a guideline threshold but with significant cardiometabolic risk factors may have a stronger clinical case for treatment than a patient with a higher body mass index but no other risk factors. A practitioner is integrating all of these inputs at once.

The Edmonton Obesity Staging System

Australian clinical practice increasingly references the Edmonton Obesity Staging System, a clinical framework that classifies obesity severity by the impact of weight-related complications on the patient's medical, mental, and functional health rather than by body mass index alone. The framework uses five stages, from stage 0, where no obesity-related health issues are present, to stage 4, where end-stage complications dominate.

The Edmonton system has been adapted into the Edmonton Obesity Staging System-2 Risk Tool, a screening instrument developed using data from the Australian Health Survey and designed for use in Australian primary care. Research using Australian Health Survey data found that approximately 78% of adults with overweight or obesity in the sample met the criteria for Edmonton stage 2 or above, indicating clinically meaningful obesity-related complications.

What this means in practice is that an increasing number of Australian practitioners will look at body mass index alongside an assessment of the patient's medical, mental, and functional health to form a fuller picture of clinical severity before reaching a treatment recommendation.

What Practitioners Look at: A Summary

The table below summarises the inputs Australian practitioners typically use when assessing whether prescription weight loss medication may be considered. The table reports the clinical framework. It is not a personal eligibility checklist.

Australian guidelines, including the Australian Obesity Management Algorithm, are explicit that medication is one element of a broader plan that includes lifestyle, dietary, and behavioural support, rather than a standalone intervention.

Conditions That May Weigh Against a Prescription

A responsible clinical assessment also considers reasons a particular medication may not be appropriate. These include:

• pregnancy, breastfeeding, or plans to become pregnant in the near future

• medical conditions that interact with the medication or with the patient's other treatments

• a current active eating disorder

• significant mental health concerns that need to be addressed first

• medications the patient is already taking that may interact

• specific historical conditions that affect the choice of treatment

When one or more of these factors apply, the practitioner may recommend a different pathway, additional investigations, or a referral to another professional before any prescribing decision is made. Patients should not interpret this as the conversation being closed off. It often means the practitioner is recommending a safer or more appropriate sequence of steps.

The Role of Previous Weight Management Efforts

Most Australian guidelines treat medication as one element of a broader plan that also includes lifestyle, dietary, and behavioural support. A practitioner will typically ask:

• what the patient has tried before

• how the patient responded

• whether weight was regained and why

• what supports the patient has had access to

• what supports are available now

This conversation is not a test. It informs the plan. The answer may be that the patient has tried many things; it may also be that the patient has not had structured support. Both situations can be valid starting points for a clinical conversation. The Australian Obesity Management Algorithm describes a tiered approach in which lifestyle support is the foundation for all patients, and additional interventions, including medication and surgical pathways, are layered on for patients whose clinical situation supports them.

Mental Health Screening and Disordered Eating

Screening for mental health and disordered eating is part of responsible practice in this area. A practitioner will typically ask about:

• past and current mental health conditions, including anxiety and depression

• past and current eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, and other patterns

• a history of restrictive eating, compensatory behaviours, or significant weight cycling

• the relationship between weight, mood, and behaviour

These questions are not designed to rule patients out. They are designed to make sure the recommended plan is appropriate. In some cases, a practitioner will recommend that mental health support comes first, or that a different professional be involved in the broader plan.

What Happens If a Practitioner Decides Medication Is Not Appropriate

Some consultations end with the practitioner deciding that medication is not the right step at this time. This is a clinical decision, not a refusal of care. The practitioner will typically:

• explain the reasoning

• recommend an alternative approach, which may include lifestyle, behavioural, or psychological support

• request further investigations before re-assessing

• refer the patient to another professional, such as a dietitian, psychologist, exercise physiologist, general practitioner, or specialist

• offer to review the position again at a later time, when the picture has changed

Patients who are surprised by this outcome can ask the practitioner to explain the reasoning. They can also seek a second opinion from another practitioner if they wish.

Frequently Asked Questions

Is there a minimum BMI to be considered for weight loss medication in Australia?

Australian clinical guidelines reference a body mass index of 30 or above, or 27 or above when a weight-related health condition is also present, as starting points for considering medication. Lower thresholds apply for patients of Asian, South Asian, and Aboriginal and Torres Strait Islander backgrounds. These are starting points for clinical conversation, not eligibility tests a patient can apply to themselves.

Can I be considered if I do not have other health conditions?

A practitioner can consider any patient who is concerned about weight. The combination of body mass index and the broader clinical picture shapes the recommendation, and standard guidelines reference a body mass index of 30 or above as a clearer starting point in the absence of other weight-related conditions.

Do I need a referral from my GP?

There is no national rule that requires a GP referral for a weight management consultation. Some services request recent pathology or coordinate with the patient's GP. A practitioner will explain what is needed for that specific consultation.

What if my BMI is just above or below a guideline figure?

The clinical picture matters more than the number alone. A practitioner will look at waist circumference, coexisting conditions, cardiometabolic markers, and the patient's history together. Frameworks such as the Edmonton Obesity Staging System are designed precisely to bring this broader picture into the assessment rather than relying on body mass index in isolation.

Will the practitioner repeat tests my GP has already done?

Practitioners generally rely on recent results where they are available, and request new tests only when the existing results do not give them enough information to make a safe decision. Bringing recent results from a GP can make the consultation more efficient.

Does the PBS use the same BMI thresholds for subsidy?

PBS subsidy depends on the specific medication and the indication it is listed for. Where subsidy is available, the PBS eligibility rules sometimes use thresholds that differ from the general clinical starting points and include lower thresholds for some patient groups. The authoritative source is pbs.gov.au, and a practitioner can confirm the current PBS position for any medication being considered.

Further Information

For authoritative Australian information on clinical assessment and eligibility considerations, useful sources include:

• The Royal Australian College of General Practitioners (racgp.org.au), including its preventive activities resource and obesity position statements

• The National Health and Medical Research Council (nhmrc.gov.au), which maintains the national Clinical Practice Guidelines and is consulting on updated guidelines through the Department of Health and Aged Care

• The Australian Obesity Management Algorithm, developed by ANZOS, ADS, ANZMOSS, and RACGP

• Healthdirect Australia (healthdirect.gov.au)

• The Pharmaceutical Benefits Scheme (pbs.gov.au)

• The Australian Health Practitioner Regulation Agency (ahpra.gov.au)

This article is general information only and does not replace individualised medical advice. Please speak with a registered Australian healthcare practitioner about your own circumstances.